Catalyst Capital Advisors’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-232	Closed	-$5K	–	462
2018 Q1	$5K	Hold	232	–	–	﹤0.01%	355
2017 Q4	$4K	Buy	+232	New	+$4K	﹤0.01%	348